Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia (EDELIFE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04980638
Recruitment Status : Recruiting
First Posted : July 28, 2021
Last Update Posted : May 2, 2022
Pierre Fabre Medicament (co-sponsor)
IQVIA (clinical CRO)
Information provided by (Responsible Party):
EspeRare Foundation